Yao, H., Tong, X., & Wang, M. (2021). Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase. Ther Adv Med Oncol.
Chicago Style aipamenaYao, Hang-Ping, Xiang-Min Tong, and Ming-Hai Wang. "Oncogenic Mechanism-based Pharmaceutical Validation of Therapeutics Targeting MET Receptor Tyrosine Kinase." Ther Adv Med Oncol 2021.
MLA aipamenaYao, Hang-Ping, Xiang-Min Tong, and Ming-Hai Wang. "Oncogenic Mechanism-based Pharmaceutical Validation of Therapeutics Targeting MET Receptor Tyrosine Kinase." Ther Adv Med Oncol 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.